Nivestym — 300 ug/0.5 mL, Solution for injection, carton of 1 × 0.5 mL prefilled syringes

Nivestym — 300 ug/0.5 mL, Solution for injection, carton of 1 × 0.5 mL prefilled syringes

Nivestym (filgrastim-aafi) is a solution for injection for subcutaneous use. NIVESTYM is a leukocyte growth factor indicated to • Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever. Supplied as carton of 1 × 0.5 mL prefilled syringes; NDC 0069-0291-01; manufacturer Pfizer Laboratories Div Pfizer Inc. Rx only. Store NIVESTYM in the refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Avoid freezing; if frozen, thaw in the refrigerator before administration.

• Active ingredient or product type: FILGRASTIM
• Strength/concentration: 300 ug/0.5 mL
• Dosage form and route: Solution for injection, Subcutaneous
• Exact package presentation: carton of 1 × 0.5 mL prefilled syringes
• NDC/item number: 0069-0291-01
• Manufacturer/labeler: Pfizer Laboratories Div Pfizer Inc
• Storage/handling: Store NIVESTYM in the refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Avoid freezing; if frozen, thaw in the refrigerator before administration. Storage Store NIVESTYM in the refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
• Status: Rx only

Important safety information: • Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.